Comparison of the effect of rupivacaine - Dexedodomidineon reduction of acute pain after cesarean sectio
Phase 2
Recruiting
- Conditions
- cesarean section.Acute pain, not elsewhere classifiedG89.1
- Registration Number
- IRCT20191026045246N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Elective Cesarean section with Class I and II ASA
Exclusion Criteria
Preterm labor (less than 37 weeks)
asthma
cardiovascular disease
preeclampsia
history of seizures,
becoming spinal anesthesia to complete anesthesia
history of chronic pain such as low back pain and fibromyalgia,
opioid use
mood and Psychological disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: 2, 4, 8, 12 and 24 hours after surgery. Method of measurement: Visual Analog Scale.
- Secondary Outcome Measures
Name Time Method The patient's first time complaining of pain. Timepoint: The first time a patient feels pain after surgery. Method of measurement: Minutes.;The amount of analgesic drug. Timepoint: The onset of pain. Method of measurement: Mg / kg.;Rupivacaine. Timepoint: Before surgery. Method of measurement: Mg / kg.;Dexedodomidine. Timepoint: Before surgery. Method of measurement: Mg / kg.;Fentanyl. Timepoint: Before surgery. Method of measurement: Mg / kg.